Get the message

0Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Proving to be temperature-insensitive and cost-effective, mRNA looks to be the answer to effective vaccine development. As a highly versatile and non-toxic molecule, it has already shown considerable potential across many therapeutic applications.

Cite

CITATION STYLE

APA

Hoerr, I. (2014). Get the message. Innovations in Pharmaceutical Technology, (51), 12–15. https://doi.org/10.1177/0146167214533130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free